Merck stops Gardasil shipments to China, hitting 2025 outlook; shares tumble
Merck said on Tuesday it would not ship its HPV vaccine Gardasil in China until at least the middle of this year due to weak ...
Merck shares plunge as company pauses Gardasil vaccine shipments in China, hurting 2025 outlook
Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...
Fact-checking Warren's claim about RFK Jr.'s work on vaccine lawsuits
During health secretary nominee Robert F. Kennedy Jr.'s Jan. 29 Senate confirmation hearing, Sen. Elizabeth Warren, D-Mass., ...
IFLScience9d
HPV Vaccines And Cervical Cancer Prevention: Where Are We Now?
HPV vaccines aim to prevent the development of HPV-related cancers by stopping the viral infection from taking hold in the ...
Merck 2025 sales forecast underwhelms as it pauses Gardasil sales in China
Shares of Merck are sliding in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales ...
Merck Shares Hit After Guidance Falls Short, Gardasil Challenge
The drugmaker’s guidance was affected by a pause in shipments of its top-selling vaccine to China from February through at ...
How a 12-year-old is raising awareness for preventing cervical cancer
At just 12 years old, Juliana recently attended a cervical cancer summit and is now leading the way to help raise awareness ...
Merck 4Q Earnings Rise; 2025 Outlook Hits Shares -- Update
Merck said it expected sales of $64.1 billion to $65.5 billion in 2025 and adjusted earnings of $8.88 to $9.03 a share. Both forecasts came in below the average analyst expectation for revenue of ...